[
    [
        {
            "time": "",
            "original_text": "医药投向标|美商务部实体清单披露无CXO列入 百济神州上市首日破发 君实生物疫苗子公司完成12.75亿元A轮融资",
            "features": {
                "keywords": [
                    "百济神州",
                    "上市首日破发",
                    "君实生物",
                    "疫苗子公司",
                    "12.75亿元A轮融资",
                    "美商务部实体清单",
                    "CXO"
                ],
                "sentiment_score": -0.3,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "医药投向标|美商务部实体清单披露无CXO列入 百济神州上市首日破发 君实生物疫苗子公司完成12.75亿元A轮融资",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 7,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        }
    ]
]